- Title
-
Oncostatin M and Kit-Ligand Control Hematopoietic Stem Cell Fate during Zebrafish Embryogenesis
- Authors
- Mahony, C.B., Pasche, C., Bertrand, J.Y.
- Source
- Full text @ Stem Cell Reports
EXPRESSION / LABELING:
|
|
|
EXPRESSION / LABELING:
PHENOTYPE:
|
|
|
MO validation and knockdown of kita, kitb and kitlgb. (A, B) Schematic of splice blocking MO targeting intron/exon junctions in kita and kitb (schematics are not to scale), along with qPCR analysis of kita and kitb expression after MO injection at different concentrations. Data is mean±SD. cDNA was synthesised from total RNA extracted at 24hpf from a pool of 6-10 embryos. (C) Schematic of second splice blocking MO targeting intron/exon junctions in kitb. (D) ISH to examine runx1 (28hpf) expression. runx1 was reduced in a similar manner as in embryos injected with kitb MO#1. kitb MO#2 was only used here, all other data uses kitb MO#1 (herein referred to as kitb MO). (E) Validation of kitlgb MO that induces exon skipping (confirmed by cDNA synthesis at 24hpf from pools of 6-10 embryos, then sequencing PCR product using reverse primer). (F) kitlgb morphants have reduced runx1 (28hpf) expression, which is rescued by injecting full length mRNA for kitlgb. (G) rag1 expression following MO injection. (H) ISH to examine macrophages (mfap4 expression) and neutrophils (mpx expression). Flk1:eGFP/gata1:DsRed embryos were used to examine blood flow and endothelial cell formation. (I-K) Analysis of the number of pigments on the left side of the yolk sack region in either MO or mRNA injected embryos at 48hpf. NI, non-injected control. +kitlga/+kitlgb, kitlga/kitlgb full length mRNA injected embryos. All data represents mean±SD. Statistical analysis completed using ordinary one-way ANOVA with multiple comparisons. In A, p=0.0008. In D, p=0.0002. In E, p value is less than 0.0001. ****, p<0.0001. ***, p<0.001. *, p<0.05. NS, p>0.05. ys, yolk sack. All scale bars Scale bars are 100μm, except G, where scale bar is 50μm. |
osm expression is tfec-dependent and reduces macrophage differentiation. (A) qPCR analysis of osm expression in FACS sorted tail endothelial cells from flk1:eGFP at 48hpf from non-injected or embryos injected with tfec mRNA. qPCR data shown is the mean±SEM of three data points, calculated from three independent experiments. Each separate experiment was conducted in biological triplicates, then averaged to give a single value. (B) ISH analysis of cmyb expression in non-injected or osm injected siblings (Sib.) and tfec mutants. (B’) analysis of cmyb expression within the CHT. (C) Experimental outline. (D) qPCR analysis of runx1 (p=0.5441), gata3 (p=0.9650) and cmyb (p=0.0981) expression in ikaros:eGFPhigh cells FACS sorted at 48hpf. qPCR data shown is the mean±SEM of three data points, calculated from three independent experiments. Each separate experiment was conducted in biological triplicates, then averaged to give a single value. NI, non-injected control. +osm, osm full length mRNA injected embryos. Statistical analysis was completed using an unpaired, two-tailed Student's t-test. NS, p>0.05. (E-G) ISH analysis of mpx, mfap4, gata1 at 4dpf in NI or osm injected embryos. NI, non-injected control. +osm, osm full length mRNA injected embryos. All scale bars are 100μm. |
Characterisation of ikaroshigh and ikaroslow population. (A) Thymus imaging in ikaros:eGFP 4.5dpf embryos. P=0.0031. Scale, 50μm. NI, non-injected control. +osm, osm full length mRNA injected embryos. (B) FACS sorting of ikaros:eGFPlow and ikaros:eGFPhigh cells at 48hpf from non-injected embryos. (C-P) qPCR analysis of gene expression in the low and high population. Data represented is mean±SD from biological triplicates, except in runx1, gata1 and osmr ikaros:eGFPhigh where data is biological duplicates. Statistical analysis was completed using an unpaired, two-tailed Student's t-test. ** p<0.01. |
Validation of MOs for osmr and osm. (A) Schematic of splice blocking MO targeting exon/intron junction in osmr. Schematic is not to scale. (B) qPCR analysis of osmr expression after osmr MO injection at different concentrations. Data is mean±SD. cDNA was synthesised from total RNA extracted from 24hpf embryos. (C) Schematic of second splice blocking MO targeting intron/exon junctions in osmr. (D) ISH to examine runx1 (28hpf) expression. runx1 was reduced in a similar manner as in embryos injected with osmr MO#1. osmr MO#2 was only used here, all other data uses osmr MO#1 (herein referred to as osmr MO). (E) Validation of osm MO. (F) osm morphants have reduced runx1 (28hpf) expression, which is rescued by injecting full length mRNA for osm. All scale bars are 100μm. |
osmr morphants have reduced primitive erythropoiesis but normal primitive myelopoiesis. (A) flk1, flt4 and dlc ISH expression at 28hpf in control or osmr morphants (B) gata1 ISH expression at 22hpf in control or osmr morphants. (C) O-dianisadine staining at 48hpf in control or osmr morphants. (D) Representative images of double transgenic flk1:eGFP/gata1:DsRed embryos injected with control or osmr morphants at 48hpf. (E) ISH analysis of macrophages (mfap expression) and neutrophils (mpx expression). All scale bars are 100μm. EXPRESSION / LABELING:
PHENOTYPE:
|